Carregant...
Assessing Outcomes in Prostate Cancer Clinical Trials: A 21st Century Tower of Babel
BACKGROUND: Due to the osseous distribution of prostate cancer metastases, progression is more readily identified than response in prostate cancer clinical trials. As a result, there is an increased focus on progression free survival (PFS) as a phase II endpoint. PFS, however, is vulnerable to inter...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2008
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2708077/ https://ncbi.nlm.nih.gov/pubmed/18661513 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.23719 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|